Cellular splicing and transcription regulatory protein p32 represses adenovirus major late transcription and causes hyperphosphorylation of RNA polymerase II

Journal of Virology

Volumn 80, Issue 10, 2006, Pages 5010-5020

  Öhrmalm, Christina ^a   Akusjärvi, Göran ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CELL PROTEIN P32; GLUTATHIONE TRANSFERASE; LUCIFERASE; MESSENGER RNA; RNA POLYMERASE II; SERINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS DNA;

ADENOVIRUS; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA REPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE REPRESSION; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; RNA SPLICING; SOUTHERN BLOTTING; TRANSCRIPTION REGULATION; VIRUS INFECTION; VIRUS RECOMBINANT; WESTERN BLOTTING;

ADENOVIRIDAE; CARRIER PROTEINS; CELL LINE; DNA REPLICATION; HUMANS; MITOCHONDRIAL PROTEINS; NFI TRANSCRIPTION FACTORS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); RECOMBINATION, GENETIC; REPRESSOR PROTEINS; RNA POLYMERASE II; TETRACYCLINE; TRANSCRIPTION, GENETIC;

ADENOVIRIDAE; DNA VIRUSES;

EID: 33646460096     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.80.10.5010-5020.2006     Document Type: Article

References (53)

1. Abbott, K. L., J. Archambault, H. Xiao, B. D. Nguyen, R. G. Roeder, J. Greenblatt, J. G. Omichinski, and P. Legault. 2005. Interactions of the HIV-1 Tat and RAP74 proteins with the RNA polymerase II CTD phosphatase FCP1. Biochemistry 44:2716-2731.
2. Ahn, S. H., M. Kim, and S. Buratowski. 2004. Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3′ end processing. Mol. Cell 13:67-76.
3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1995. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
4. Berenjian, S., and G. Akusjärvi. 2006. Binary AdEasy vector systems designed for Tet-ON or Tet-OFF regulated control of transgene expression. Virus Res. 115:116-123.
5. Chambers, R. S, B. Q. Wang, Z. F. Burton, and M. E. Dahmus. 1995. The activity of COOH-terminal domain phosphatase is regulated by a docking site on RNA polymerase II and by the general transcription factors IIF and IIB. J. Biol. Chem. 270:14962-14969.
6. Chattopadhyay, C., D. Hawke, R. Kobayashi, and S. N. Maity. 2004. Human p32, interacts with B subunit of the CCAAT-binding factor, CBF/NF-Y, and inhibits CBF-mediated transcription activation in vitro. Nucleic Acids Res. 32:3632-3641.
7. Cheng, C., and P. A. Sharp. 2003. RNA polymerase 11 accumulation in the promoter-proximal region of the dihydrofolate reductase and γ-actin genes. Mol. Cell. Biol. 23:1961-1967.
8. Cho, E. J., M. S. Kobor, M. Kim, J. Greenblatt, and S. Buratowski. 2001. Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain. Genes Dev. 15:3319-3329.
9. Cho, H., T. K. Kim, H. Mancebo, W. S. Lane, O. Flores, and D. Reinberg. 1999. A protein phosphatase functions to recycle RNA polymerase II. Genes Dev. 13:1540-1552.
10. Edholm, D., M. Molin, E. Bajak, and G. Akusjärvi. 2001. Adenovirus vector designed for expression of toxic proteins. J. Virol. 75:9579-9584.
11. Goldstrohm, A. C., A. L. Greenleaf, and M. A. Garcia-Blanco. 2001. Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing. Gene 277:31-47.
12. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
13. Hall, K. T., M. S. Giles, M. A. Calderwood, D. J. Goodwin, D. A. Matthews, and A. Whitehouse. 2002. The herpesvirus saimiri open reading frame 73 gene product interacts with the cellular protein p32. J. Virol. 76:11612-11622.
14. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
15. Imperiale, M., G. Akusjärvi, and K. Leppard. 1995. Post-transcriptional control of adenovirus gene expression. Curr. Top. Microbiol. Immunol. 199:139-171.
16. Kim, Y. K., C. F. Bourgeois, C. Isel, M. J. Churcher, and J. Karn. 2002. Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation. Mol. Cell. Biol. 22:4622-4637.
17. Kobor, M. S., L. D. Simon, J. Omichinski, G. Zhong, J. Archambault, and J. Greenblatt. 2000. A motif shared by TFIIF and TFIIB mediates their interaction with the RNA polymerase II carboxy-terminal domain phosphatase Fcp1p in Saccharomyces cerevisiae. Mol. Cell. Biol. 20:7438-7449.
18. Komarnitsky, P., E. J. Cho, and S. Buratowski. 2000. Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev. 14:2452-2460.
19. Krainer, A. R., G. C. Conway, and D. Kozak. 1990. Purification and characterization of pre-mRNA splicing factor SF2 from HeLa cells. Genes Dev. 4:1158-1171.
20. Larsson, S., C. Svensson, and G. Akusjärvi. 1992. Control of adenovirus major late gene expression at multiple levels. J. Mol. Biol. 225:287-298.
21. Lee, K. A., A. Bindereif, and M. R. Green. 1988. A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal. Tech. 5:22-31.
22. Liang, X., Y. C. Shin, R. E. Means, and J. U. Jung. 2004. Inhibition of interferon-mediated antiviral activity by murine gammaherpesvirus 68 latency-associated M2 protein. J. Virol. 78:12416-12427.
23. Lindås, A. C., and B. Tomkinson. 2005. Identification and characterization of the promoter for the gene encoding human tripeptidyl-peptidase II. Gene 345:249-257.
24. Lucas, J. J., and H. S. Ginsberg. 1971. Synthesis of virus-specific ribonucleic acid in KB cells infected with type 2 adenovirus. J. Virol. 8:203-214.
25. Luo, Y., H. Yu, and B. M. Peterlin. 1994. Cellular protein modulates effects of human immunodeficiency virus type 1 Rev. J. Virol. 68:3850-3856.
26. Maderious, A., and S. Chen-Kiang. 1984. Pausing and premature termination of human RNA polymerase II during transcription of adenovirus in vivo and in vitro. Proc. Natl. Acad. Sci. USA 81:5931-5935.
27. Maity, S. N., P. T. Golumbek, G. Karsenty, and B. de Crombrugghe. 1988. Selective activation of transcription by a novel CCAAT binding factor. Science 241:582-585.
28. Mandal, S. S., H. Cho, S. Kim, K. Cabane, and D. Reinberg. 2002. FCP1, a phosphatase specific for the heptapeptide repeat of the largest subunit of RNA polymerase II, stimulates transcription elongation. Mol. Cell. Biol. 22:7543-7552.
29. Maniatis, T., and R. Reed. 2002. An extensive network of coupling among gene expression machines. Nature 416:499-506.
30. Marshall, N. F., G. K. Dahmus, and M. E. Dahmus. 1998. Regulation of carboxyl-terminal domain phosphatase by HIV-1 tat protein. J. Biol. Chem. 273:31726-31730.
31. Matthews, D. A., and W. C. Russell. 1998. Adenovirus core protein V interacts with p32-a protein which is associated with both the mitochondria and the nucleus. J. Gen. Virol. 79:1677-1685.
32. Moisan, A., C. Larochelle, B. Guillemette, and L. Gaudreau. 2004. BRCA1 can modulate RNA polymerase II carboxy-terminal domain phosphorylation levels. Mol. Cell. Biol. 24:6947-6956.
33. Molin, M., L. Bouakaz, S. Berenjian, and G. Akusjärvi. 2002. Unscheduled expression of capsid protein IIIa results in defects in adenovirus major late mRNA and protein expression. Virus Res. 83:197-206.
34. Molin, M., M. C. Shoshan, K. Ohman-Forslund, S. Linder, and G. Akusjärvi. 1998. Two novel adenovirus vector systems permitting regulated protein expression in gene transfer experiments. J. Virol. 72:8358-8361.
35. Mühlemann, O., and G. Akusjärvi. 1998. Preparation of splicing-competent nuclear extracts from adenovirus-infected cells, p. 203-216. In W. S. M. Wold (ed.), Methods in molecular medicine, vol. 21. Humana Press Inc., Totowa, N.J.
36. Ni, Z., B. E. Schwartz, J. Werner, J. R. Suarez, and J. T. Lis. 2004. Coordination of transcription, RNA processing, and surveillance by P-TEFb kinase on heat shock genes. Mol. Cell 13:55-65.
37. O'Brien, T., S. Hardin, A. Greenleaf, and J. T. Lis. 1994. Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation. Nature 370:75-77.
38. Palancade, B., and O. Bensaude. 2003. Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation. Eur. J. Biochem. 270:3859-3870.
39. Petersen-Mahrt, S. K., C. Estmer, C. Öhrmalm, D. A. Matthews, W. C. Russell, and G. Akusjärvi. 1999. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation. EMBO J. 18:1014-1024.
40. Prage, L., U. Pettersson, S. Höglund, K. Londberg-Holm, and L. Philipson. 1968. Structural proteins of adenoviruses IV. Sequential degradation of the adenovirus type 2 virion. Virology 42:341-358.
41. Resnekov, O., E. Ben-Asher, E. Bengal, M. Choder, N. Hay, M. Kessler, N. Ragimov, M. Seiberg, H. Skolnik-David, and Y. Aloni. 1988. Transcription termination in animal viruses and cells. Gene 72:91-104.
42. Schroeder, S. C., B. Schwer, S. Shuman, and D. Bentley. 2000. Dynamic association of capping enzymes with transcribing RNA polymerase II. Genes Dev. 14:2435-2440.
43. Song, B., and C. S. Young. 1998. Functional analysis of the CAAT box in the major late promoter of the subgroup C human adenoviruses. J. Virol. 72:3213-3220.
44. Stow, N. D. 1981. Cloning of a DNA fragment from the left-hand terminus of the adenovirus type 2 genome and its use in site-directed mutagenesis. J. Virol. 37:171-180.
45. Thomas, G. P., and M. B. Mathews. 1980. DNA replication and the early to late transition in adenovirus infection. Cell 22:523-533.
46. Van Scoy, S., I. Watakabe, A. R. Krainer, and J. Hearing. 2000. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication. Virology 275:145-157.
47. Virtanen, A., P. Gilardi, A. Näslund, J. M. LeMoullec, U. Pettersson, and M. Perricaudet. 1984. mRNAs from human adenovirus 2 early region 4. J. Virol. 51:822-831.
48. Wolgemuth, D. J., and M. T. Hsu. 1981. Visualization of nascent RNA transcripts and simultaneous transcription and replication in viral nucleoprotein complexes from adenovirus 2-infected HeLa cells. J. Mol. Biol. 147:247-268.
49. Xu, Y. X., Y. Hirose, X. Z. Zhou, K. P. Lu, and J. L. Manley. 2003. Pin1 modulates the structure and function of human RNA polymerase II. Genes Dev. 17:2765-2776.
50. Yeo, M., P. S. Lin, M. E. Dahmus, and G. N. Gill. 2003. A novel RNA polymerase II C-terminal domain phosphatase that preferentially dephosphorylates serine 5. J. Biol. Chem. 278:26078-26085.
51. Yu, L., P. M. Loewenstein, Z. Zhang, and M. Green. 1995. In vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAP. J. Virol. 69:3017-3023.
52. Zheng, Y. H., H. F. Yu, and B. M. Peterlin. 2003. Human p32 protein relieves a posttranscriptional block to HIV replication in murine cells. Nat. Cell Biol. 5:611-618.
53. Zhou, M., M. A. Halanski, M. F. Radonovich, F. Kashanchi, J. Peng, D. H. Price, and J. N. Brady. 2000. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol. Cell. Biol. 20:5077-5086.